Global Point of Care Glucose Testing Market Analysis By Product Type (Glucose Meters, Test Strips & Lancets, Others), By Application (Type-1 Diabetes, Type-2 Diabetes), By End User (Hospitals and Clinics, Home Care Settings, Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Dec 2024
- Report ID: 135199
- Number of Pages: 325
- Format:
-
-
-
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Nipro Corporation Company Profile
- PlatInium Equity Advisors LLC (Lifescan Inc.)
- Nova Biomedical
- ACON Laboratories
- Trividia Health Inc.
- Prodigy Diabetes Care LLC
- Bayer AG/Ascensia Diabetes Care Holdings AG
- EKF Diagnostics
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |